Sign In
31 Mar 2009 10:49
ο»Ώ
Β
Immediate Release
31 March 2009
ReGen Therapeutics Plc
('ReGen' or the Company')
Total Voting Rights
For the purposes of the Disclosure and Transparency Rules of the Financial Services Authority, the Board of ReGen is required to notify the market of the following:
As at the date of this announcement, the Company's issued share capital consists of 20,580,550Β ordinaryΒ shares with a nominal value ofΒ 0.01Β p each, with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury.
Therefore the total number of Ordinary Shares in the CompanyΒ with voting rights is 20,580,550.
The above figure of 20,580,550Β Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Service Authority's Disclosure and Transparency Rules.
ENDS
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
RolandΒ Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel:Β 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9800
Follow the stocks
